Why the study?
Does flow-mediated dilatation (FMD) provide better reliability and reproducibility than peripheral arterial tonometry (PAT) for assessing endothelial function in patients with coronary heart disease?
Population
18 volunteers with coronary heart disease
Comparison
Flow-mediated dilatation by means of brachial… vs Peripheral arterial tonometry with the EndoPAT…
Design
Cross-sectional
Follow-up
2 days
Authors
Loading...
FMD may be preferred for endothelial function testing in coronary heart disease; leaves open outcome prediction or therapy guidance.
Does flow-mediated dilatation (FMD) provide better reliability and reproducibility than peripheral arterial tonometry (PAT) for assessing endothelial function in patients with coronary heart disease?
FMD demonstrates better within-day reliability and lower typical errors of measurement compared to PAT for assessing endothelial function in patients with coronary heart disease.
Onkelinx et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: